Anticoagulant effect of Huisheng Oral Solution in a rat model of thrombosis
The aim of this study was to investigate whether Huisheng Oral Solution has an anticoagulant effect in a rat model of thrombosis. Forty male SD rats were equally and randomly divided into four groups: blank group, model group, and two treatment groups (A and B). Rats were subcutaneously injected...
Ausführliche Beschreibung
Autor*in: |
Liu Shuang-Qing [verfasserIn] Guo Jiang-Ying [verfasserIn] Deng Qun [verfasserIn] He Zhong-Jie [verfasserIn] Lei Shu-Hong [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2013 |
---|
Schlagwörter: |
---|
Übergeordnetes Werk: |
In: Archives of Biological Sciences - University of Belgrade, University of Novi Sad, 2010, 65(2013), 3, Seite 1223-1231 |
---|---|
Übergeordnetes Werk: |
volume:65 ; year:2013 ; number:3 ; pages:1223-1231 |
Links: |
Link aufrufen |
---|
DOI / URN: |
10.2298/ABS1303223L |
---|
Katalog-ID: |
DOAJ027291898 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | DOAJ027291898 | ||
003 | DE-627 | ||
005 | 20230307112801.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230226s2013 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.2298/ABS1303223L |2 doi | |
035 | |a (DE-627)DOAJ027291898 | ||
035 | |a (DE-599)DOAJcffd23ed4a7547d58c2cebf86370e18c | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
050 | 0 | |a QH301-705.5 | |
100 | 0 | |a Liu Shuang-Qing |e verfasserin |4 aut | |
245 | 1 | 0 | |a Anticoagulant effect of Huisheng Oral Solution in a rat model of thrombosis |
264 | 1 | |c 2013 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a The aim of this study was to investigate whether Huisheng Oral Solution has an anticoagulant effect in a rat model of thrombosis. Forty male SD rats were equally and randomly divided into four groups: blank group, model group, and two treatment groups (A and B). Rats were subcutaneously injected with carrageenan to induce thrombosis. Rats in treatment group A were intragastrically administered with Huisheng Oral Solution in a dose of 2 mL/100 g body weight (once per 8 h) 72 h after carrageenan injection, and those in treatment group B both 72 h before and after the induction of thrombosis. Blood samples were collected 24, 48, and 72 h after carrageenan injection for measurements of prothrombin time (PT), activated partial thromboplastin time (APTT), international normalized ratio (INR), fibrinogen (FIB), prothrombin activity (PTA), platelets (PLT), fibrin degradation products (FDPs), and D-dimer. Lung, liver and mesentery samples were taken 72 h after carrageenan injection for histopathological analysis. The number of microthrombi in sections of different tissue samples were counted under a microscope. Blood parameters among each group were compared using the Welch test, Kruskal-Wallis test or SNK test after testing for normality, while the number of microthrombi was compared using the Bonferroni test. Compared to the model group, PT, APTT, INR, and FIB levels at the majority of time points were significantly shorter or lower in the two treatment groups (P <0.05 for all), but the PTA was not significantly improved in the treatment groups. The levels of FDPs and D-dimer and PLT counts at the majority of time points were significantly lower (P <0.05 for all), and the numbers of microthrombi in the lung, liver and mesentery samples were significantly decreased (P <0.05 for all) in the two treatment groups. The above parameters at the majority of time points showed no significant differences between the two treatment groups. We conclude that Huisheng Oral Solution can significantly improve coagulation parameters, fibrinolysis parameters, and PLT count, and reduce blood hypercoagulability and microthrombosis suggesting that Huisheng Oral Solution has an anticoagulant effect in a rat model of thrombosis. | ||
650 | 4 | |a Huisheng Oral Solution | |
650 | 4 | |a hypercoagulable state | |
650 | 4 | |a microthrombus | |
650 | 4 | |a fibrinolysis | |
650 | 4 | |a thrombosis | |
653 | 0 | |a Biology (General) | |
700 | 0 | |a Guo Jiang-Ying |e verfasserin |4 aut | |
700 | 0 | |a Deng Qun |e verfasserin |4 aut | |
700 | 0 | |a He Zhong-Jie |e verfasserin |4 aut | |
700 | 0 | |a Lei Shu-Hong |e verfasserin |4 aut | |
773 | 0 | 8 | |i In |t Archives of Biological Sciences |d University of Belgrade, University of Novi Sad, 2010 |g 65(2013), 3, Seite 1223-1231 |w (DE-627)538998008 |w (DE-600)2380842-1 |x 18214339 |7 nnns |
773 | 1 | 8 | |g volume:65 |g year:2013 |g number:3 |g pages:1223-1231 |
856 | 4 | 0 | |u https://doi.org/10.2298/ABS1303223L |z kostenfrei |
856 | 4 | 0 | |u https://doaj.org/article/cffd23ed4a7547d58c2cebf86370e18c |z kostenfrei |
856 | 4 | 0 | |u http://www.doiserbia.nb.rs/img/doi/0354-4664/2013/0354-46641303223L.pdf |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/0354-4664 |y Journal toc |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/1821-4339 |y Journal toc |z kostenfrei |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_DOAJ | ||
912 | |a GBV_ILN_20 | ||
912 | |a GBV_ILN_22 | ||
912 | |a GBV_ILN_23 | ||
912 | |a GBV_ILN_24 | ||
912 | |a GBV_ILN_31 | ||
912 | |a GBV_ILN_39 | ||
912 | |a GBV_ILN_40 | ||
912 | |a GBV_ILN_62 | ||
912 | |a GBV_ILN_63 | ||
912 | |a GBV_ILN_65 | ||
912 | |a GBV_ILN_69 | ||
912 | |a GBV_ILN_70 | ||
912 | |a GBV_ILN_73 | ||
912 | |a GBV_ILN_74 | ||
912 | |a GBV_ILN_95 | ||
912 | |a GBV_ILN_105 | ||
912 | |a GBV_ILN_110 | ||
912 | |a GBV_ILN_151 | ||
912 | |a GBV_ILN_161 | ||
912 | |a GBV_ILN_170 | ||
912 | |a GBV_ILN_213 | ||
912 | |a GBV_ILN_230 | ||
912 | |a GBV_ILN_285 | ||
912 | |a GBV_ILN_293 | ||
912 | |a GBV_ILN_602 | ||
912 | |a GBV_ILN_2014 | ||
912 | |a GBV_ILN_4012 | ||
912 | |a GBV_ILN_4037 | ||
912 | |a GBV_ILN_4112 | ||
912 | |a GBV_ILN_4125 | ||
912 | |a GBV_ILN_4126 | ||
912 | |a GBV_ILN_4249 | ||
912 | |a GBV_ILN_4305 | ||
912 | |a GBV_ILN_4306 | ||
912 | |a GBV_ILN_4307 | ||
912 | |a GBV_ILN_4313 | ||
912 | |a GBV_ILN_4322 | ||
912 | |a GBV_ILN_4323 | ||
912 | |a GBV_ILN_4324 | ||
912 | |a GBV_ILN_4325 | ||
912 | |a GBV_ILN_4338 | ||
912 | |a GBV_ILN_4367 | ||
912 | |a GBV_ILN_4700 | ||
951 | |a AR | ||
952 | |d 65 |j 2013 |e 3 |h 1223-1231 |
author_variant |
l s q lsq g j y gjy d q dq h z j hzj l s h lsh |
---|---|
matchkey_str |
article:18214339:2013----::nioglnefcohihnoasltoiaam |
hierarchy_sort_str |
2013 |
callnumber-subject-code |
QH |
publishDate |
2013 |
allfields |
10.2298/ABS1303223L doi (DE-627)DOAJ027291898 (DE-599)DOAJcffd23ed4a7547d58c2cebf86370e18c DE-627 ger DE-627 rakwb eng QH301-705.5 Liu Shuang-Qing verfasserin aut Anticoagulant effect of Huisheng Oral Solution in a rat model of thrombosis 2013 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier The aim of this study was to investigate whether Huisheng Oral Solution has an anticoagulant effect in a rat model of thrombosis. Forty male SD rats were equally and randomly divided into four groups: blank group, model group, and two treatment groups (A and B). Rats were subcutaneously injected with carrageenan to induce thrombosis. Rats in treatment group A were intragastrically administered with Huisheng Oral Solution in a dose of 2 mL/100 g body weight (once per 8 h) 72 h after carrageenan injection, and those in treatment group B both 72 h before and after the induction of thrombosis. Blood samples were collected 24, 48, and 72 h after carrageenan injection for measurements of prothrombin time (PT), activated partial thromboplastin time (APTT), international normalized ratio (INR), fibrinogen (FIB), prothrombin activity (PTA), platelets (PLT), fibrin degradation products (FDPs), and D-dimer. Lung, liver and mesentery samples were taken 72 h after carrageenan injection for histopathological analysis. The number of microthrombi in sections of different tissue samples were counted under a microscope. Blood parameters among each group were compared using the Welch test, Kruskal-Wallis test or SNK test after testing for normality, while the number of microthrombi was compared using the Bonferroni test. Compared to the model group, PT, APTT, INR, and FIB levels at the majority of time points were significantly shorter or lower in the two treatment groups (P <0.05 for all), but the PTA was not significantly improved in the treatment groups. The levels of FDPs and D-dimer and PLT counts at the majority of time points were significantly lower (P <0.05 for all), and the numbers of microthrombi in the lung, liver and mesentery samples were significantly decreased (P <0.05 for all) in the two treatment groups. The above parameters at the majority of time points showed no significant differences between the two treatment groups. We conclude that Huisheng Oral Solution can significantly improve coagulation parameters, fibrinolysis parameters, and PLT count, and reduce blood hypercoagulability and microthrombosis suggesting that Huisheng Oral Solution has an anticoagulant effect in a rat model of thrombosis. Huisheng Oral Solution hypercoagulable state microthrombus fibrinolysis thrombosis Biology (General) Guo Jiang-Ying verfasserin aut Deng Qun verfasserin aut He Zhong-Jie verfasserin aut Lei Shu-Hong verfasserin aut In Archives of Biological Sciences University of Belgrade, University of Novi Sad, 2010 65(2013), 3, Seite 1223-1231 (DE-627)538998008 (DE-600)2380842-1 18214339 nnns volume:65 year:2013 number:3 pages:1223-1231 https://doi.org/10.2298/ABS1303223L kostenfrei https://doaj.org/article/cffd23ed4a7547d58c2cebf86370e18c kostenfrei http://www.doiserbia.nb.rs/img/doi/0354-4664/2013/0354-46641303223L.pdf kostenfrei https://doaj.org/toc/0354-4664 Journal toc kostenfrei https://doaj.org/toc/1821-4339 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 65 2013 3 1223-1231 |
spelling |
10.2298/ABS1303223L doi (DE-627)DOAJ027291898 (DE-599)DOAJcffd23ed4a7547d58c2cebf86370e18c DE-627 ger DE-627 rakwb eng QH301-705.5 Liu Shuang-Qing verfasserin aut Anticoagulant effect of Huisheng Oral Solution in a rat model of thrombosis 2013 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier The aim of this study was to investigate whether Huisheng Oral Solution has an anticoagulant effect in a rat model of thrombosis. Forty male SD rats were equally and randomly divided into four groups: blank group, model group, and two treatment groups (A and B). Rats were subcutaneously injected with carrageenan to induce thrombosis. Rats in treatment group A were intragastrically administered with Huisheng Oral Solution in a dose of 2 mL/100 g body weight (once per 8 h) 72 h after carrageenan injection, and those in treatment group B both 72 h before and after the induction of thrombosis. Blood samples were collected 24, 48, and 72 h after carrageenan injection for measurements of prothrombin time (PT), activated partial thromboplastin time (APTT), international normalized ratio (INR), fibrinogen (FIB), prothrombin activity (PTA), platelets (PLT), fibrin degradation products (FDPs), and D-dimer. Lung, liver and mesentery samples were taken 72 h after carrageenan injection for histopathological analysis. The number of microthrombi in sections of different tissue samples were counted under a microscope. Blood parameters among each group were compared using the Welch test, Kruskal-Wallis test or SNK test after testing for normality, while the number of microthrombi was compared using the Bonferroni test. Compared to the model group, PT, APTT, INR, and FIB levels at the majority of time points were significantly shorter or lower in the two treatment groups (P <0.05 for all), but the PTA was not significantly improved in the treatment groups. The levels of FDPs and D-dimer and PLT counts at the majority of time points were significantly lower (P <0.05 for all), and the numbers of microthrombi in the lung, liver and mesentery samples were significantly decreased (P <0.05 for all) in the two treatment groups. The above parameters at the majority of time points showed no significant differences between the two treatment groups. We conclude that Huisheng Oral Solution can significantly improve coagulation parameters, fibrinolysis parameters, and PLT count, and reduce blood hypercoagulability and microthrombosis suggesting that Huisheng Oral Solution has an anticoagulant effect in a rat model of thrombosis. Huisheng Oral Solution hypercoagulable state microthrombus fibrinolysis thrombosis Biology (General) Guo Jiang-Ying verfasserin aut Deng Qun verfasserin aut He Zhong-Jie verfasserin aut Lei Shu-Hong verfasserin aut In Archives of Biological Sciences University of Belgrade, University of Novi Sad, 2010 65(2013), 3, Seite 1223-1231 (DE-627)538998008 (DE-600)2380842-1 18214339 nnns volume:65 year:2013 number:3 pages:1223-1231 https://doi.org/10.2298/ABS1303223L kostenfrei https://doaj.org/article/cffd23ed4a7547d58c2cebf86370e18c kostenfrei http://www.doiserbia.nb.rs/img/doi/0354-4664/2013/0354-46641303223L.pdf kostenfrei https://doaj.org/toc/0354-4664 Journal toc kostenfrei https://doaj.org/toc/1821-4339 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 65 2013 3 1223-1231 |
allfields_unstemmed |
10.2298/ABS1303223L doi (DE-627)DOAJ027291898 (DE-599)DOAJcffd23ed4a7547d58c2cebf86370e18c DE-627 ger DE-627 rakwb eng QH301-705.5 Liu Shuang-Qing verfasserin aut Anticoagulant effect of Huisheng Oral Solution in a rat model of thrombosis 2013 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier The aim of this study was to investigate whether Huisheng Oral Solution has an anticoagulant effect in a rat model of thrombosis. Forty male SD rats were equally and randomly divided into four groups: blank group, model group, and two treatment groups (A and B). Rats were subcutaneously injected with carrageenan to induce thrombosis. Rats in treatment group A were intragastrically administered with Huisheng Oral Solution in a dose of 2 mL/100 g body weight (once per 8 h) 72 h after carrageenan injection, and those in treatment group B both 72 h before and after the induction of thrombosis. Blood samples were collected 24, 48, and 72 h after carrageenan injection for measurements of prothrombin time (PT), activated partial thromboplastin time (APTT), international normalized ratio (INR), fibrinogen (FIB), prothrombin activity (PTA), platelets (PLT), fibrin degradation products (FDPs), and D-dimer. Lung, liver and mesentery samples were taken 72 h after carrageenan injection for histopathological analysis. The number of microthrombi in sections of different tissue samples were counted under a microscope. Blood parameters among each group were compared using the Welch test, Kruskal-Wallis test or SNK test after testing for normality, while the number of microthrombi was compared using the Bonferroni test. Compared to the model group, PT, APTT, INR, and FIB levels at the majority of time points were significantly shorter or lower in the two treatment groups (P <0.05 for all), but the PTA was not significantly improved in the treatment groups. The levels of FDPs and D-dimer and PLT counts at the majority of time points were significantly lower (P <0.05 for all), and the numbers of microthrombi in the lung, liver and mesentery samples were significantly decreased (P <0.05 for all) in the two treatment groups. The above parameters at the majority of time points showed no significant differences between the two treatment groups. We conclude that Huisheng Oral Solution can significantly improve coagulation parameters, fibrinolysis parameters, and PLT count, and reduce blood hypercoagulability and microthrombosis suggesting that Huisheng Oral Solution has an anticoagulant effect in a rat model of thrombosis. Huisheng Oral Solution hypercoagulable state microthrombus fibrinolysis thrombosis Biology (General) Guo Jiang-Ying verfasserin aut Deng Qun verfasserin aut He Zhong-Jie verfasserin aut Lei Shu-Hong verfasserin aut In Archives of Biological Sciences University of Belgrade, University of Novi Sad, 2010 65(2013), 3, Seite 1223-1231 (DE-627)538998008 (DE-600)2380842-1 18214339 nnns volume:65 year:2013 number:3 pages:1223-1231 https://doi.org/10.2298/ABS1303223L kostenfrei https://doaj.org/article/cffd23ed4a7547d58c2cebf86370e18c kostenfrei http://www.doiserbia.nb.rs/img/doi/0354-4664/2013/0354-46641303223L.pdf kostenfrei https://doaj.org/toc/0354-4664 Journal toc kostenfrei https://doaj.org/toc/1821-4339 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 65 2013 3 1223-1231 |
allfieldsGer |
10.2298/ABS1303223L doi (DE-627)DOAJ027291898 (DE-599)DOAJcffd23ed4a7547d58c2cebf86370e18c DE-627 ger DE-627 rakwb eng QH301-705.5 Liu Shuang-Qing verfasserin aut Anticoagulant effect of Huisheng Oral Solution in a rat model of thrombosis 2013 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier The aim of this study was to investigate whether Huisheng Oral Solution has an anticoagulant effect in a rat model of thrombosis. Forty male SD rats were equally and randomly divided into four groups: blank group, model group, and two treatment groups (A and B). Rats were subcutaneously injected with carrageenan to induce thrombosis. Rats in treatment group A were intragastrically administered with Huisheng Oral Solution in a dose of 2 mL/100 g body weight (once per 8 h) 72 h after carrageenan injection, and those in treatment group B both 72 h before and after the induction of thrombosis. Blood samples were collected 24, 48, and 72 h after carrageenan injection for measurements of prothrombin time (PT), activated partial thromboplastin time (APTT), international normalized ratio (INR), fibrinogen (FIB), prothrombin activity (PTA), platelets (PLT), fibrin degradation products (FDPs), and D-dimer. Lung, liver and mesentery samples were taken 72 h after carrageenan injection for histopathological analysis. The number of microthrombi in sections of different tissue samples were counted under a microscope. Blood parameters among each group were compared using the Welch test, Kruskal-Wallis test or SNK test after testing for normality, while the number of microthrombi was compared using the Bonferroni test. Compared to the model group, PT, APTT, INR, and FIB levels at the majority of time points were significantly shorter or lower in the two treatment groups (P <0.05 for all), but the PTA was not significantly improved in the treatment groups. The levels of FDPs and D-dimer and PLT counts at the majority of time points were significantly lower (P <0.05 for all), and the numbers of microthrombi in the lung, liver and mesentery samples were significantly decreased (P <0.05 for all) in the two treatment groups. The above parameters at the majority of time points showed no significant differences between the two treatment groups. We conclude that Huisheng Oral Solution can significantly improve coagulation parameters, fibrinolysis parameters, and PLT count, and reduce blood hypercoagulability and microthrombosis suggesting that Huisheng Oral Solution has an anticoagulant effect in a rat model of thrombosis. Huisheng Oral Solution hypercoagulable state microthrombus fibrinolysis thrombosis Biology (General) Guo Jiang-Ying verfasserin aut Deng Qun verfasserin aut He Zhong-Jie verfasserin aut Lei Shu-Hong verfasserin aut In Archives of Biological Sciences University of Belgrade, University of Novi Sad, 2010 65(2013), 3, Seite 1223-1231 (DE-627)538998008 (DE-600)2380842-1 18214339 nnns volume:65 year:2013 number:3 pages:1223-1231 https://doi.org/10.2298/ABS1303223L kostenfrei https://doaj.org/article/cffd23ed4a7547d58c2cebf86370e18c kostenfrei http://www.doiserbia.nb.rs/img/doi/0354-4664/2013/0354-46641303223L.pdf kostenfrei https://doaj.org/toc/0354-4664 Journal toc kostenfrei https://doaj.org/toc/1821-4339 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 65 2013 3 1223-1231 |
allfieldsSound |
10.2298/ABS1303223L doi (DE-627)DOAJ027291898 (DE-599)DOAJcffd23ed4a7547d58c2cebf86370e18c DE-627 ger DE-627 rakwb eng QH301-705.5 Liu Shuang-Qing verfasserin aut Anticoagulant effect of Huisheng Oral Solution in a rat model of thrombosis 2013 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier The aim of this study was to investigate whether Huisheng Oral Solution has an anticoagulant effect in a rat model of thrombosis. Forty male SD rats were equally and randomly divided into four groups: blank group, model group, and two treatment groups (A and B). Rats were subcutaneously injected with carrageenan to induce thrombosis. Rats in treatment group A were intragastrically administered with Huisheng Oral Solution in a dose of 2 mL/100 g body weight (once per 8 h) 72 h after carrageenan injection, and those in treatment group B both 72 h before and after the induction of thrombosis. Blood samples were collected 24, 48, and 72 h after carrageenan injection for measurements of prothrombin time (PT), activated partial thromboplastin time (APTT), international normalized ratio (INR), fibrinogen (FIB), prothrombin activity (PTA), platelets (PLT), fibrin degradation products (FDPs), and D-dimer. Lung, liver and mesentery samples were taken 72 h after carrageenan injection for histopathological analysis. The number of microthrombi in sections of different tissue samples were counted under a microscope. Blood parameters among each group were compared using the Welch test, Kruskal-Wallis test or SNK test after testing for normality, while the number of microthrombi was compared using the Bonferroni test. Compared to the model group, PT, APTT, INR, and FIB levels at the majority of time points were significantly shorter or lower in the two treatment groups (P <0.05 for all), but the PTA was not significantly improved in the treatment groups. The levels of FDPs and D-dimer and PLT counts at the majority of time points were significantly lower (P <0.05 for all), and the numbers of microthrombi in the lung, liver and mesentery samples were significantly decreased (P <0.05 for all) in the two treatment groups. The above parameters at the majority of time points showed no significant differences between the two treatment groups. We conclude that Huisheng Oral Solution can significantly improve coagulation parameters, fibrinolysis parameters, and PLT count, and reduce blood hypercoagulability and microthrombosis suggesting that Huisheng Oral Solution has an anticoagulant effect in a rat model of thrombosis. Huisheng Oral Solution hypercoagulable state microthrombus fibrinolysis thrombosis Biology (General) Guo Jiang-Ying verfasserin aut Deng Qun verfasserin aut He Zhong-Jie verfasserin aut Lei Shu-Hong verfasserin aut In Archives of Biological Sciences University of Belgrade, University of Novi Sad, 2010 65(2013), 3, Seite 1223-1231 (DE-627)538998008 (DE-600)2380842-1 18214339 nnns volume:65 year:2013 number:3 pages:1223-1231 https://doi.org/10.2298/ABS1303223L kostenfrei https://doaj.org/article/cffd23ed4a7547d58c2cebf86370e18c kostenfrei http://www.doiserbia.nb.rs/img/doi/0354-4664/2013/0354-46641303223L.pdf kostenfrei https://doaj.org/toc/0354-4664 Journal toc kostenfrei https://doaj.org/toc/1821-4339 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 65 2013 3 1223-1231 |
language |
English |
source |
In Archives of Biological Sciences 65(2013), 3, Seite 1223-1231 volume:65 year:2013 number:3 pages:1223-1231 |
sourceStr |
In Archives of Biological Sciences 65(2013), 3, Seite 1223-1231 volume:65 year:2013 number:3 pages:1223-1231 |
format_phy_str_mv |
Article |
institution |
findex.gbv.de |
topic_facet |
Huisheng Oral Solution hypercoagulable state microthrombus fibrinolysis thrombosis Biology (General) |
isfreeaccess_bool |
true |
container_title |
Archives of Biological Sciences |
authorswithroles_txt_mv |
Liu Shuang-Qing @@aut@@ Guo Jiang-Ying @@aut@@ Deng Qun @@aut@@ He Zhong-Jie @@aut@@ Lei Shu-Hong @@aut@@ |
publishDateDaySort_date |
2013-01-01T00:00:00Z |
hierarchy_top_id |
538998008 |
id |
DOAJ027291898 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ027291898</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230307112801.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230226s2013 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2298/ABS1303223L</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ027291898</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJcffd23ed4a7547d58c2cebf86370e18c</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">QH301-705.5</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Liu Shuang-Qing</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Anticoagulant effect of Huisheng Oral Solution in a rat model of thrombosis</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2013</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The aim of this study was to investigate whether Huisheng Oral Solution has an anticoagulant effect in a rat model of thrombosis. Forty male SD rats were equally and randomly divided into four groups: blank group, model group, and two treatment groups (A and B). Rats were subcutaneously injected with carrageenan to induce thrombosis. Rats in treatment group A were intragastrically administered with Huisheng Oral Solution in a dose of 2 mL/100 g body weight (once per 8 h) 72 h after carrageenan injection, and those in treatment group B both 72 h before and after the induction of thrombosis. Blood samples were collected 24, 48, and 72 h after carrageenan injection for measurements of prothrombin time (PT), activated partial thromboplastin time (APTT), international normalized ratio (INR), fibrinogen (FIB), prothrombin activity (PTA), platelets (PLT), fibrin degradation products (FDPs), and D-dimer. Lung, liver and mesentery samples were taken 72 h after carrageenan injection for histopathological analysis. The number of microthrombi in sections of different tissue samples were counted under a microscope. Blood parameters among each group were compared using the Welch test, Kruskal-Wallis test or SNK test after testing for normality, while the number of microthrombi was compared using the Bonferroni test. Compared to the model group, PT, APTT, INR, and FIB levels at the majority of time points were significantly shorter or lower in the two treatment groups (P <0.05 for all), but the PTA was not significantly improved in the treatment groups. The levels of FDPs and D-dimer and PLT counts at the majority of time points were significantly lower (P <0.05 for all), and the numbers of microthrombi in the lung, liver and mesentery samples were significantly decreased (P <0.05 for all) in the two treatment groups. The above parameters at the majority of time points showed no significant differences between the two treatment groups. We conclude that Huisheng Oral Solution can significantly improve coagulation parameters, fibrinolysis parameters, and PLT count, and reduce blood hypercoagulability and microthrombosis suggesting that Huisheng Oral Solution has an anticoagulant effect in a rat model of thrombosis.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Huisheng Oral Solution</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">hypercoagulable state</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">microthrombus</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">fibrinolysis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">thrombosis</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Biology (General)</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Guo Jiang-Ying</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Deng Qun</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">He Zhong-Jie</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Lei Shu-Hong</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Archives of Biological Sciences</subfield><subfield code="d">University of Belgrade, University of Novi Sad, 2010</subfield><subfield code="g">65(2013), 3, Seite 1223-1231</subfield><subfield code="w">(DE-627)538998008</subfield><subfield code="w">(DE-600)2380842-1</subfield><subfield code="x">18214339</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:65</subfield><subfield code="g">year:2013</subfield><subfield code="g">number:3</subfield><subfield code="g">pages:1223-1231</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.2298/ABS1303223L</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/cffd23ed4a7547d58c2cebf86370e18c</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.doiserbia.nb.rs/img/doi/0354-4664/2013/0354-46641303223L.pdf</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/0354-4664</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1821-4339</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">65</subfield><subfield code="j">2013</subfield><subfield code="e">3</subfield><subfield code="h">1223-1231</subfield></datafield></record></collection>
|
callnumber-first |
Q - Science |
author |
Liu Shuang-Qing |
spellingShingle |
Liu Shuang-Qing misc QH301-705.5 misc Huisheng Oral Solution misc hypercoagulable state misc microthrombus misc fibrinolysis misc thrombosis misc Biology (General) Anticoagulant effect of Huisheng Oral Solution in a rat model of thrombosis |
authorStr |
Liu Shuang-Qing |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)538998008 |
format |
electronic Article |
delete_txt_mv |
keep |
author_role |
aut aut aut aut aut |
collection |
DOAJ |
remote_str |
true |
callnumber-label |
QH301-705 |
illustrated |
Not Illustrated |
issn |
18214339 |
topic_title |
QH301-705.5 Anticoagulant effect of Huisheng Oral Solution in a rat model of thrombosis Huisheng Oral Solution hypercoagulable state microthrombus fibrinolysis thrombosis |
topic |
misc QH301-705.5 misc Huisheng Oral Solution misc hypercoagulable state misc microthrombus misc fibrinolysis misc thrombosis misc Biology (General) |
topic_unstemmed |
misc QH301-705.5 misc Huisheng Oral Solution misc hypercoagulable state misc microthrombus misc fibrinolysis misc thrombosis misc Biology (General) |
topic_browse |
misc QH301-705.5 misc Huisheng Oral Solution misc hypercoagulable state misc microthrombus misc fibrinolysis misc thrombosis misc Biology (General) |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
cr |
hierarchy_parent_title |
Archives of Biological Sciences |
hierarchy_parent_id |
538998008 |
hierarchy_top_title |
Archives of Biological Sciences |
isfreeaccess_txt |
true |
familylinks_str_mv |
(DE-627)538998008 (DE-600)2380842-1 |
title |
Anticoagulant effect of Huisheng Oral Solution in a rat model of thrombosis |
ctrlnum |
(DE-627)DOAJ027291898 (DE-599)DOAJcffd23ed4a7547d58c2cebf86370e18c |
title_full |
Anticoagulant effect of Huisheng Oral Solution in a rat model of thrombosis |
author_sort |
Liu Shuang-Qing |
journal |
Archives of Biological Sciences |
journalStr |
Archives of Biological Sciences |
callnumber-first-code |
Q |
lang_code |
eng |
isOA_bool |
true |
recordtype |
marc |
publishDateSort |
2013 |
contenttype_str_mv |
txt |
container_start_page |
1223 |
author_browse |
Liu Shuang-Qing Guo Jiang-Ying Deng Qun He Zhong-Jie Lei Shu-Hong |
container_volume |
65 |
class |
QH301-705.5 |
format_se |
Elektronische Aufsätze |
author-letter |
Liu Shuang-Qing |
doi_str_mv |
10.2298/ABS1303223L |
author2-role |
verfasserin |
title_sort |
anticoagulant effect of huisheng oral solution in a rat model of thrombosis |
callnumber |
QH301-705.5 |
title_auth |
Anticoagulant effect of Huisheng Oral Solution in a rat model of thrombosis |
abstract |
The aim of this study was to investigate whether Huisheng Oral Solution has an anticoagulant effect in a rat model of thrombosis. Forty male SD rats were equally and randomly divided into four groups: blank group, model group, and two treatment groups (A and B). Rats were subcutaneously injected with carrageenan to induce thrombosis. Rats in treatment group A were intragastrically administered with Huisheng Oral Solution in a dose of 2 mL/100 g body weight (once per 8 h) 72 h after carrageenan injection, and those in treatment group B both 72 h before and after the induction of thrombosis. Blood samples were collected 24, 48, and 72 h after carrageenan injection for measurements of prothrombin time (PT), activated partial thromboplastin time (APTT), international normalized ratio (INR), fibrinogen (FIB), prothrombin activity (PTA), platelets (PLT), fibrin degradation products (FDPs), and D-dimer. Lung, liver and mesentery samples were taken 72 h after carrageenan injection for histopathological analysis. The number of microthrombi in sections of different tissue samples were counted under a microscope. Blood parameters among each group were compared using the Welch test, Kruskal-Wallis test or SNK test after testing for normality, while the number of microthrombi was compared using the Bonferroni test. Compared to the model group, PT, APTT, INR, and FIB levels at the majority of time points were significantly shorter or lower in the two treatment groups (P <0.05 for all), but the PTA was not significantly improved in the treatment groups. The levels of FDPs and D-dimer and PLT counts at the majority of time points were significantly lower (P <0.05 for all), and the numbers of microthrombi in the lung, liver and mesentery samples were significantly decreased (P <0.05 for all) in the two treatment groups. The above parameters at the majority of time points showed no significant differences between the two treatment groups. We conclude that Huisheng Oral Solution can significantly improve coagulation parameters, fibrinolysis parameters, and PLT count, and reduce blood hypercoagulability and microthrombosis suggesting that Huisheng Oral Solution has an anticoagulant effect in a rat model of thrombosis. |
abstractGer |
The aim of this study was to investigate whether Huisheng Oral Solution has an anticoagulant effect in a rat model of thrombosis. Forty male SD rats were equally and randomly divided into four groups: blank group, model group, and two treatment groups (A and B). Rats were subcutaneously injected with carrageenan to induce thrombosis. Rats in treatment group A were intragastrically administered with Huisheng Oral Solution in a dose of 2 mL/100 g body weight (once per 8 h) 72 h after carrageenan injection, and those in treatment group B both 72 h before and after the induction of thrombosis. Blood samples were collected 24, 48, and 72 h after carrageenan injection for measurements of prothrombin time (PT), activated partial thromboplastin time (APTT), international normalized ratio (INR), fibrinogen (FIB), prothrombin activity (PTA), platelets (PLT), fibrin degradation products (FDPs), and D-dimer. Lung, liver and mesentery samples were taken 72 h after carrageenan injection for histopathological analysis. The number of microthrombi in sections of different tissue samples were counted under a microscope. Blood parameters among each group were compared using the Welch test, Kruskal-Wallis test or SNK test after testing for normality, while the number of microthrombi was compared using the Bonferroni test. Compared to the model group, PT, APTT, INR, and FIB levels at the majority of time points were significantly shorter or lower in the two treatment groups (P <0.05 for all), but the PTA was not significantly improved in the treatment groups. The levels of FDPs and D-dimer and PLT counts at the majority of time points were significantly lower (P <0.05 for all), and the numbers of microthrombi in the lung, liver and mesentery samples were significantly decreased (P <0.05 for all) in the two treatment groups. The above parameters at the majority of time points showed no significant differences between the two treatment groups. We conclude that Huisheng Oral Solution can significantly improve coagulation parameters, fibrinolysis parameters, and PLT count, and reduce blood hypercoagulability and microthrombosis suggesting that Huisheng Oral Solution has an anticoagulant effect in a rat model of thrombosis. |
abstract_unstemmed |
The aim of this study was to investigate whether Huisheng Oral Solution has an anticoagulant effect in a rat model of thrombosis. Forty male SD rats were equally and randomly divided into four groups: blank group, model group, and two treatment groups (A and B). Rats were subcutaneously injected with carrageenan to induce thrombosis. Rats in treatment group A were intragastrically administered with Huisheng Oral Solution in a dose of 2 mL/100 g body weight (once per 8 h) 72 h after carrageenan injection, and those in treatment group B both 72 h before and after the induction of thrombosis. Blood samples were collected 24, 48, and 72 h after carrageenan injection for measurements of prothrombin time (PT), activated partial thromboplastin time (APTT), international normalized ratio (INR), fibrinogen (FIB), prothrombin activity (PTA), platelets (PLT), fibrin degradation products (FDPs), and D-dimer. Lung, liver and mesentery samples were taken 72 h after carrageenan injection for histopathological analysis. The number of microthrombi in sections of different tissue samples were counted under a microscope. Blood parameters among each group were compared using the Welch test, Kruskal-Wallis test or SNK test after testing for normality, while the number of microthrombi was compared using the Bonferroni test. Compared to the model group, PT, APTT, INR, and FIB levels at the majority of time points were significantly shorter or lower in the two treatment groups (P <0.05 for all), but the PTA was not significantly improved in the treatment groups. The levels of FDPs and D-dimer and PLT counts at the majority of time points were significantly lower (P <0.05 for all), and the numbers of microthrombi in the lung, liver and mesentery samples were significantly decreased (P <0.05 for all) in the two treatment groups. The above parameters at the majority of time points showed no significant differences between the two treatment groups. We conclude that Huisheng Oral Solution can significantly improve coagulation parameters, fibrinolysis parameters, and PLT count, and reduce blood hypercoagulability and microthrombosis suggesting that Huisheng Oral Solution has an anticoagulant effect in a rat model of thrombosis. |
collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 |
container_issue |
3 |
title_short |
Anticoagulant effect of Huisheng Oral Solution in a rat model of thrombosis |
url |
https://doi.org/10.2298/ABS1303223L https://doaj.org/article/cffd23ed4a7547d58c2cebf86370e18c http://www.doiserbia.nb.rs/img/doi/0354-4664/2013/0354-46641303223L.pdf https://doaj.org/toc/0354-4664 https://doaj.org/toc/1821-4339 |
remote_bool |
true |
author2 |
Guo Jiang-Ying Deng Qun He Zhong-Jie Lei Shu-Hong |
author2Str |
Guo Jiang-Ying Deng Qun He Zhong-Jie Lei Shu-Hong |
ppnlink |
538998008 |
callnumber-subject |
QH - Natural History and Biology |
mediatype_str_mv |
c |
isOA_txt |
true |
hochschulschrift_bool |
false |
doi_str |
10.2298/ABS1303223L |
callnumber-a |
QH301-705.5 |
up_date |
2024-07-04T01:07:02.861Z |
_version_ |
1803608625368793088 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ027291898</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230307112801.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230226s2013 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2298/ABS1303223L</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ027291898</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJcffd23ed4a7547d58c2cebf86370e18c</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">QH301-705.5</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Liu Shuang-Qing</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Anticoagulant effect of Huisheng Oral Solution in a rat model of thrombosis</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2013</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The aim of this study was to investigate whether Huisheng Oral Solution has an anticoagulant effect in a rat model of thrombosis. Forty male SD rats were equally and randomly divided into four groups: blank group, model group, and two treatment groups (A and B). Rats were subcutaneously injected with carrageenan to induce thrombosis. Rats in treatment group A were intragastrically administered with Huisheng Oral Solution in a dose of 2 mL/100 g body weight (once per 8 h) 72 h after carrageenan injection, and those in treatment group B both 72 h before and after the induction of thrombosis. Blood samples were collected 24, 48, and 72 h after carrageenan injection for measurements of prothrombin time (PT), activated partial thromboplastin time (APTT), international normalized ratio (INR), fibrinogen (FIB), prothrombin activity (PTA), platelets (PLT), fibrin degradation products (FDPs), and D-dimer. Lung, liver and mesentery samples were taken 72 h after carrageenan injection for histopathological analysis. The number of microthrombi in sections of different tissue samples were counted under a microscope. Blood parameters among each group were compared using the Welch test, Kruskal-Wallis test or SNK test after testing for normality, while the number of microthrombi was compared using the Bonferroni test. Compared to the model group, PT, APTT, INR, and FIB levels at the majority of time points were significantly shorter or lower in the two treatment groups (P <0.05 for all), but the PTA was not significantly improved in the treatment groups. The levels of FDPs and D-dimer and PLT counts at the majority of time points were significantly lower (P <0.05 for all), and the numbers of microthrombi in the lung, liver and mesentery samples were significantly decreased (P <0.05 for all) in the two treatment groups. The above parameters at the majority of time points showed no significant differences between the two treatment groups. We conclude that Huisheng Oral Solution can significantly improve coagulation parameters, fibrinolysis parameters, and PLT count, and reduce blood hypercoagulability and microthrombosis suggesting that Huisheng Oral Solution has an anticoagulant effect in a rat model of thrombosis.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Huisheng Oral Solution</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">hypercoagulable state</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">microthrombus</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">fibrinolysis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">thrombosis</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Biology (General)</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Guo Jiang-Ying</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Deng Qun</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">He Zhong-Jie</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Lei Shu-Hong</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Archives of Biological Sciences</subfield><subfield code="d">University of Belgrade, University of Novi Sad, 2010</subfield><subfield code="g">65(2013), 3, Seite 1223-1231</subfield><subfield code="w">(DE-627)538998008</subfield><subfield code="w">(DE-600)2380842-1</subfield><subfield code="x">18214339</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:65</subfield><subfield code="g">year:2013</subfield><subfield code="g">number:3</subfield><subfield code="g">pages:1223-1231</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.2298/ABS1303223L</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/cffd23ed4a7547d58c2cebf86370e18c</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.doiserbia.nb.rs/img/doi/0354-4664/2013/0354-46641303223L.pdf</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/0354-4664</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1821-4339</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">65</subfield><subfield code="j">2013</subfield><subfield code="e">3</subfield><subfield code="h">1223-1231</subfield></datafield></record></collection>
|
score |
7.4003057 |